Category: Morton
-
Revive Therapeutics (RVV.C) latest spate of Bucillamine research could slow COVID-19 infection rates
Revive Therapeutics (RVV.C) signed a research agreement with the University of California, San Francisco (UCSF) to explore Bucillamine as a potential treatment for severe cases of COVID-19 today, according to a press release. The research will be done by Dr. John Fahy with the intention of testing the efficacy of Bucillamine in pre-clinical models of…
-
KWESST Micro Systems (KWE.V) provides communications technology to resolve warfare’s greatest challenge
‘The secret of war lies in the communications,’ Napoleon Bonaparte Napoleon enjoyed many advantages over Wellington at the outset of the Battle of Waterloo—numerical superiority and familiarity of territory being two—but what he lacked and what ultimately cost him the war, was Wellington’s efficient communication system. What Waterloo teaches us is that it doesn’t matter…
-
Perimeter Medical Imaging AI (PINK.V) latest study is the latest assault in the war on cancer
More than terrorism, drugs, racial animus and acts of God, cancer has always been with us. It’s humanity’s number one enemy throughout history—it’s only recently that we’ve learned what little we know, and devised rudimentary strategies on how to secure its defeat. The statistics are harrowing. Do a headcount next time during your commute then…
-
Predictmedix (PMED.C) tech suite acquisition Symp2Pass adds functionality and growth opportunities
Predictmedix (PMED.C) has inked an letter of intent (LOI) to acquire AI and IoT tech suite, Symp2Pass, and are working on the definitive agreement today, according to a press release. The acquisition will help bolster PMED’s growth prospects and will align the product’s company sales with their stated goal of being the first line of…
-
Revive Therapeutics (RVV.C) finds $23 million and throws it at their bucillamine clinical studies
Revive Therapeutics (RVV.C) provided an update on their Phase 3 clinical trial for bucillamine for COVID-19 today. Primarily, the update’s about funding and more specifically their recent $23 million financing. The company intends to use the monies to fund their aggressive expansion from14 clinical sites to 50 to meet their enrolment requires for the study…
-
Gold Mountain Mining (GMTN.V) raises $10 million to go ahead with Elk Gold Project
Gold Mountain Mining (GMTN.V) closed a brokered private placement, lead by Cannacord Genuity and Gravitas Securities, issuing 10,310,000 units at $0.97 per unit, and pulled in $10,000,700. The company intends on using the cash raised to advance their Elk Gold Project and for working capital and general corporate purposes. “Through successfully completing this offering, we…
-
FansUnite Entertainment (FANS.C) enlists compliance firm, OneComply, to aid the bounce into American gambling jurisdiction
Fansunite Entertainment (FANS.C) has forged a partnership with Vancouver-based compliance and licensing solution OneComply to offer advice on protocol and strategy on entering other legalized North American gambling hotspots today, according to a press release. This moves comes shortly after the repeal of the Professional and Amateur Sports Protection Act (PASPA), which has orchestrated a…
-
FansUnite Entertainment (FANS.C) supplies iGaming platform for esports sportsbook
FansUnite Entertainment (FANS.C) subsidiary Askott Entertainment will supply its iGaming platform, Chameleon, for an esports sportsbook soon to be formed by its FANS partner GameCo and US Bookmaking and Sky Ute Casino, according to a press release. FansUnite will be the first iGaming solutions provider to get considerable exposure to the U.S. esports betting market…
-
Vext Science (VEXT.C) enters California market and records a COVID-19 era loss of only $1 million
If you stop and think about it, the fact that Vext Science (VEXT.C) only lost USD$1 million in Q1 of 2020 is fantastic. Today’s news, of their joint operation with Green Goblin Inc. of San Diego, California, for extraction, distillation and kitchen operations today is only of moderate importance. Granted, it’s the next natural step…
-
The strange story of SoftBank’s rich weirdo CEO, Masayoshi Son
I’ve always wanted to be a rich weirdo. Like Nicolas Cage marrying Lisa-Marie Presley on a whim to feel close to her Dad, buying two private islands, collecting shrunken pygmy heads and living in Anne Rice’s old house in the Garden District of New Orleans weird. But those things get old, and eventually I’d want…